Carl L Gordon's Net Worth
Carl L Gordon's net worth is estimated to be at least $58,603,971.30 as of 07/03/2025. CoreStreet's estimation of Carl L Gordon's net worth is based on their sale of stock and current holding of stock.
Carl L Gordon is Director at Compass Therapeutics Inc.. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,571,428 units of CMPX stock on 04/09/2025. Their biggest sale was on 08/13/2024 when they sold 250,000 units of Keros Therapeutics Inc stock for $11,002,500.00. They typically trade 2 times per year.
Total value of insider buys:
- $38,885,700.17
Total value of insider sells:
- $19,718,271.13
Most recent insider trade:
- April 9, 2025
Carl L Gordon's Insider Trading History
| Compass Therapeutics Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 9, 2025 | Director | 3,571,428 | $1.59 | Sell | $5,678,570.52 |
May 13, 2022 | Director | 30,722 | $2.49 | Buy | $76,497.78 |
May 11, 2022 | Director | 64,700 | $1.79 | Buy | $115,813.00 |
Nov. 4, 2021 | Director | 5,357,143 | $3.50 | Buy | $18,750,000.50 |
| Keros Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 13, 2024 | Director | 250,000 | $44.01 | Sell | $11,002,500.00 |
| Terns Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 15, 2024 | Director | 50,976 | $10.00 | Sell | $509,760.00 |
| Theseus Pharmaceuticals Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 17, 2023 | Director | 479,932 | $3.05 | Buy | $1,463,792.60 |
Nov. 7, 2022 | Director | 192,000 | $5.21 | Buy | $1,000,320.00 |
| Adicet Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 27, 2023 | Director | 875,000 | $2.09 | Buy | $1,828,750.00 |
| Kinnate Biopharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 1, 2023 | Director | 716,157 | $2.62 | Buy | $1,876,331.34 |
April 28, 2023 | Director | 350,749 | $2.55 | Buy | $894,409.95 |
Feb. 14, 2022 | Director | 30,700 | $9.95 | Buy | $305,465.00 |
Feb. 11, 2022 | Director | 156,000 | $10.22 | Buy | $1,594,320.00 |
| Oric Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 29, 2021 | Director | 75,555 | $23.31 | Sell | $1,761,187.05 |
March 22, 2021 | Director | 7,673 | $26.47 | Sell | $203,104.31 |
March 19, 2021 | Director | 21,275 | $26.47 | Sell | $563,149.25 |
| Turning Point Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 22, 2019 | Director | 360,000 | $18.00 | Buy | $6,480,000.00 |
| Intellia Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 11, 2016 | Director | 250,000 | $18.00 | Buy | $4,500,000.00 |